Literature DB >> 22365732

Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.

A Finkenstedt1, A Widschwendter, C G Brasse-Lagnel, I Theurl, M Hubalek, H Dieplinger, C Tselepis, D G Ward, W Vogel, H Zoller.   

Abstract

Increased maternal and foetal iron requirements during pregnancy are compensated by an increase of intestinal iron absorption. Animal studies have shown that the expression of the main iron regulator hepcidin is significantly suppressed during pregnancy, but the factors associated with hepcidin suppression remain unknown. To investigate possible suppressors of hepcidin expression during pregnancy we determined serum concentrations of growth-differentiation factor-15 (GDF15), erythropoietin (EPO), soluble hemojuvelin (HJV) and hepcidin in 42 pregnant women at different time points of gestation and correlated them with serum iron and haematological parameters. Serum iron parameters and serum hepcidin concentration significantly decreased during pregnancy, whereas serum concentrations of GDF15, EPO and soluble HJV significantly increased. A negative correlation of hepcidin with EPO and soluble HJV but no correlation between hepcidin and GDF15 was found. Hepcidin and ferritin were positively correlated throughout the pregnancy. Our findings suggest that hepcidin expression is controlled by body iron stores where soluble HJV and EPO may act as suppressors of hepcidin. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365732     DOI: 10.1016/j.bcmd.2012.02.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  10 in total

1.  A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum.

Authors:  Wenjie Chen; Chia Chi Sun; Shanzhuo Chen; Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

2.  Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Levent Cem Mutlu; Nejat Altintas; Murat Aydin; Feti Tulubas; Mustafa Oran; Volkan Kucukyalin; Gizem Kaplan; Ahmet Gurel
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

Review 3.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

Review 4.  The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.

Authors:  Kimberly Zumbrennen-Bullough; Jodie L Babitt
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

5.  Hepcidin and Iron Metabolism in Pregnancy: Correlation with Smoking and Birth Weight and Length.

Authors:  Magdalena Chełchowska; Jadwiga Ambroszkiewicz; Joanna Gajewska; Ewa Jabłońska-Głąb; Tomasz M Maciejewski; Mariusz Ołtarzewski
Journal:  Biol Trace Elem Res       Date:  2016-01-20       Impact factor: 3.738

6.  Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.

Authors:  Cornel S G Mirciov; Sarah J Wilkins; Linda A Dunn; Gregory J Anderson; David M Frazer
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

7.  Serum hepcidin and iron status parameters in pregnant women and the association with adverse maternal and fetal outcomes: a study protocol for a prospective cohort study.

Authors:  Gabriela Amstad Bencaiova; Deborah Ruth Vogt; Irene Hoesli
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

Review 8.  Hepcidin and iron homeostasis during pregnancy.

Authors:  Mary Dawn Koenig; Lisa Tussing-Humphreys; Jessica Day; Brooke Cadwell; Elizabeta Nemeth
Journal:  Nutrients       Date:  2014-08-04       Impact factor: 5.717

Review 9.  Biomarkers of iron metabolism in chronic kidney disease.

Authors:  Glogowski Tomasz; Wojtaszek Ewa; Malyszko Jolanta
Journal:  Int Urol Nephrol       Date:  2020-10-06       Impact factor: 2.370

Review 10.  Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.

Authors:  Hanan Kamel M Saad; Alawiyah Awang Abd Rahman; Azly Sumanty Ab Ghani; Wan Rohani Wan Taib; Imilia Ismail; Muhammad Farid Johan; Abdullah Saleh Al-Wajeeh; Hamid Ali Nagi Al-Jamal
Journal:  Biomedicines       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.